{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:07:50Z","timestamp":1792786070531,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001794","name":"Pediatric Brain Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Musella Foundation for Brain Tumor Research & Information Inc.","id":[{"id":"https:\/\/ror.org\/0560cwj87","id-type":"ROR","asserted-by":"crossref"}]},{"name":"ChadTough Defeat DIPG Foundation"},{"DOI":"10.13039\/100008221","name":"The Cure Starts Now","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008221","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Andruzzi Foundation"},{"name":"Alex\u2019s Lemonade Stand Foundation","id":[{"id":"https:\/\/ror.org\/038ja4880","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Solving Kids\u2019 Cancer, Inc.","id":[{"id":"https:\/\/ror.org\/02xnhzs58","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Bibi Fund"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016610","name":"B+ Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IronMatt Foundation"},{"name":"St. Baldrick Foundation"},{"name":"Wong Family Translational"},{"name":"Ependymoma Foundation"},{"name":"Curing Kids Cancer Foundation","id":[{"id":"https:\/\/ror.org\/0567zyg14","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The Caroline Mortimer Fund"},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Distinguished Scientist Award"},{"DOI":"10.13039\/100006064","name":"Sontag Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006064","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alex\u2019s Lemonade Stand Foundation","id":[{"id":"https:\/\/ror.org\/038ja4880","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diffuse midline glioma (DMG) is a lethal pediatric brain tumor, driven by profound epigenetic dysregulation, raising the possibility that targeting epigenetic regulators such as histone deacetylases (HDACs) could provide a therapeutic benefit. However, despite preclinical activity, currently available HDAC inhibitors have shown limited clinical translation due to poor central nervous system (CNS) penetration and a lack of HDAC isoform selectivity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We combined CRISPR\/Cas9 screening and pharmacologic HDAC inhibition to identify isoform-specific dependencies in DMG cell lines. Mechanistic studies were performed using bulk RNA-seq and HiChIP, and therapeutic efficacy was evaluated in orthotopic patient-derived xenograft mouse models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identify that the nuclear-localized Class I HDAC isoforms are dependencies in DMG and demonstrate that HDAC2 represents a selective dependency that is highly expressed in patient tumors. We further identify a CNS-penetrant HDAC inhibitor, Compound 26, with preferential HDAC1\/2 isoform selectivity. Transcriptomic and chromatin conformation analyses reveal that Compound 26 induces rapid transcriptional reprogramming, restores physiologic pontine histone patterns, and induces cell cycle arrest through chromatin reorganization. Consistent with these effects, Compound 26 slows DMG growth in vitro and in orthotopic in vivo models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings establish HDAC2 as a critical and therapeutically actionable dependency in DMG. Genetic or pharmacological targeting of HDAC2 disrupts DMG chromatin architecture and induces cell cycle arrest. The HDAC1\/2-selective inhibitor Compound 26 exhibits favorable CNS-penetration, tolerability, and antitumor activity in disease-relevant patient-derived xenograft models. Collectively, these data support isoform-selective HDAC inhibition as a rational strategy to overcome the translational limitations of pan-HDAC inhibitors in DMG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag142","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:48:08Z","timestamp":1782388088000},"page":"2485-2499","source":"Crossref","is-referenced-by-count":0,"title":["Selective histone deacetylase inhibition as a therapeutically relevant strategy in H3K27M-glioma"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1239-3839","authenticated-orcid":false,"given":"Andrew","family":"Groves","sequence":"first","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]},{"name":"Division of Hematology\/Oncology, University of Iowa Stead Family Children\u2019s Hospital , Iowa City, Iowa,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0989-3776","authenticated-orcid":false,"given":"Orville O","family":"Kirkland","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Chemistry & Chemical Biology, Harvard University , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5161-6117","authenticated-orcid":false,"given":"Costanza","family":"Lo Cascio","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8514-0410","authenticated-orcid":false,"given":"Xiuqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3079-9745","authenticated-orcid":false,"given":"Caleb","family":"Heaslip","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7152-9655","authenticated-orcid":false,"given":"Joana","family":"Graca Marques","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Poetschke","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0540-8827","authenticated-orcid":false,"given":"Tingjian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-3552","authenticated-orcid":false,"given":"Diana H","family":"Chin","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine , Cleveland, Ohio,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-8632","authenticated-orcid":false,"given":"Yaw","family":"Asante","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Case Western Reserve University School of Medicine , Cleveland, Ohio,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4100-9509","authenticated-orcid":false,"given":"Qi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-5044","authenticated-orcid":false,"given":"Hyunmin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine , Cleveland, Ohio,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanqing","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine , Cleveland, Ohio,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2861-658X","authenticated-orcid":false,"given":"Maria","family":"Trissal","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3843-320X","authenticated-orcid":false,"given":"Jenna","family":"Labelle","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0005-3984","authenticated-orcid":false,"given":"Gustavo Alencastro","family":"Veiga Cruzeiro","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen L","family":"Jones","sequence":"additional","affiliation":[{"name":"Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9609-8134","authenticated-orcid":false,"given":"Amy B","family":"Cameron","sequence":"additional","affiliation":[{"name":"Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0574-5963","authenticated-orcid":false,"given":"Louise M","family":"Clark","sequence":"additional","affiliation":[{"name":"Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-2954","authenticated-orcid":false,"given":"Brittaney","family":"Leeper","sequence":"additional","affiliation":[{"name":"Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-4413","authenticated-orcid":false,"given":"Quang-De","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-2302","authenticated-orcid":false,"given":"Berkley E","family":"Gryder","sequence":"additional","affiliation":[{"name":"Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine , Cleveland, Ohio,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2613-8126","authenticated-orcid":false,"given":"Mariella G","family":"Filbin","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Cancer and Blood Disorders Center, Harvard Medical School , Boston, Massachusetts,","place":["USA"]},{"name":"Broad Institute of Harvard and MIT , Cambridge, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1461-3356","authenticated-orcid":false,"given":"Jun","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts,","place":["USA"]},{"name":"Department of Medicine, Harvard Medical School , Boston, Massachusetts,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"2026100502522911700_noag142-B1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11940-019-0577-y","article-title":"Diffuse intrinsic pontine glioma: from diagnosis to next-generation clinical trials","volume":"21","author":"Vitanza","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"2026100502522911700_noag142-B2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"2026100502522911700_noag142-B3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project","year":"2012","journal-title":"Nat Genet"},{"key":"2026100502522911700_noag142-B4","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1093\/neuonc\/noad164","article-title":"H3K27M mutant glioma: disease definition and biological underpinnings","volume":"26","author":"Saratsis","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026100502522911700_noag142-B5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1101\/gad.217778.113","article-title":"The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression","volume":"27","author":"Chan","year":"2013","journal-title":"Genes Dev"},{"key":"2026100502522911700_noag142-B6","doi-asserted-by":"publisher","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"2026100502522911700_noag142-B7","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026100502522911700_noag142-B8","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1073\/pnas.0903139106","article-title":"Genetic dissection of histone deacetylase requirement in tumor cells","volume":"106","author":"Haberland","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026100502522911700_noag142-B9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1242\/dev.100487","article-title":"A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralog","volume":"141","author":"Hagelkruys","year":"2014","journal-title":"Development"},{"key":"2026100502522911700_noag142-B10","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1038\/s41467-023-40776-y","article-title":"Epigenetic and molecular coordination between HDAC2 and SMAD3-SKI regulates essential brain tumour stem cell characteristics","volume":"14","author":"Bahia","year":"2023","journal-title":"Nat Commun"},{"key":"2026100502522911700_noag142-B11","doi-asserted-by":"publisher","first-page":"e149232","DOI":"10.1172\/jci.insight.149232","article-title":"Nonredundant, isoform-specific roles of HDAC1 in glioma stem cells","volume":"6","author":"Lo Cascio","year":"2021","journal-title":"JCI Insight"},{"key":"2026100502522911700_noag142-B12","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1182\/blood-2010-11-318055","article-title":"Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor\u2013induced thrombocytopenia","volume":"117","author":"Bishton","year":"2011","journal-title":"Blood"},{"key":"2026100502522911700_noag142-B13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s12032-014-0985-5","article-title":"Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience","volume":"31","author":"Bezecny","year":"2014","journal-title":"Med Oncol"},{"key":"2026100502522911700_noag142-B14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"2026100502522911700_noag142-B15","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/neuonc\/noad141","article-title":"Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium (PBTC-047)","volume":"25","author":"Monje","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026100502522911700_noag142-B16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s40478-020-00953-2","article-title":"Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients","volume":"8","author":"Guntner","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"2026100502522911700_noag142-B17","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00280-019-04021-y","article-title":"Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma","volume":"85","author":"Rodgers","year":"2020","journal-title":"Cancer Chemother Pharmacol"},{"key":"2026100502522911700_noag142-B18","doi-asserted-by":"publisher","first-page":"55360","DOI":"10.3791\/55360","article-title":"A protocol for rapid post-mortem cell culture of diffuse intrinsic pontine glioma (DIPG)","author":"Lin","year":"2017","journal-title":"J Vis Exp"},{"key":"2026100502522911700_noag142-B19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nchembio.313","article-title":"Chemical phylogenetics of histone deacetylases","volume":"6","author":"Bradner","year":"2010","journal-title":"Nat Chem Biol"},{"key":"2026100502522911700_noag142-B20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/s41596-019-0285-9","article-title":"Measurement of differential chromatin interactions with absolute quantification of architecture (AQuA-HiChIP)","volume":"15","author":"Gryder","year":"2020","journal-title":"Nat Protoc"},{"key":"2026100502522911700_noag142-B21","doi-asserted-by":"publisher","first-page":"6546","DOI":"10.1021\/acs.jmedchem.7b01925","article-title":"Detailed exploration around 4-Aminoquinolines chemical space to navigate the lysine methyltransferase G9a and DNA methyltransferase biological spaces","volume":"61","author":"Rabal","year":"2018","journal-title":"J Med Chem"},{"key":"2026100502522911700_noag142-B22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ccell.2019.09.005","article-title":"Re-programing chromatin with a bifunctional LSD1\/HDAC inhibitor induces therapeutic differentiation in DIPG","volume":"36","author":"Anastas","year":"2019","journal-title":"Cancer Cell"},{"key":"2026100502522911700_noag142-B23","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Paugh","year":"2010","journal-title":"J Clin Oncol"},{"key":"2026100502522911700_noag142-B24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41588-022-01236-3","article-title":"The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location","volume":"54","author":"Liu","year":"2022","journal-title":"Nat Genet"},{"key":"2026100502522911700_noag142-B25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1126\/science.aao4750","article-title":"Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq","volume":"360","author":"Filbin","year":"2018","journal-title":"Science (1979)"},{"key":"2026100502522911700_noag142-B26","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1158\/2159-8290.CD-21-1491","article-title":"BAF complex maintains glioma stem cells in pediatric H3K27M glioma","volume":"12","author":"Panditharatna","year":"2022","journal-title":"Cancer Discov"},{"key":"2026100502522911700_noag142-B27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nrg.2017.74","article-title":"Emerging and evolving concepts in gene essentiality","volume":"19","author":"Rancati","year":"2018","journal-title":"Nat Rev Genet"},{"key":"2026100502522911700_noag142-B28","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","article-title":"Computational correction of copy number effect improves specificity of CRISPR\u2013Cas9 essentiality screens in cancer cells","volume":"49","author":"Meyers","year":"2017","journal-title":"Nat Genet"},{"key":"2026100502522911700_noag142-B29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccell.2023.03.007","article-title":"Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities","volume":"41","author":"Sun","year":"2023","journal-title":"Cancer Cell"},{"key":"2026100502522911700_noag142-B30","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1021\/acsmedchemlett.6b00239","article-title":"Development of a potent and selective HDAC8 inhibitor","volume":"7","author":"Ingham","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"2026100502522911700_noag142-B31","doi-asserted-by":"publisher","first-page":"13162","DOI":"10.1073\/pnas.1608067113","article-title":"Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma","volume":"113","author":"Hideshima","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026100502522911700_noag142-B32","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nchembio.1223","article-title":"Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group","volume":"9","author":"Lobera","year":"2013","journal-title":"Nat Chem Biol"},{"key":"2026100502522911700_noag142-B33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"Neurotherapeutics"},{"key":"2026100502522911700_noag142-B34","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1021\/cn500021p","article-title":"Image-guided synthesis reveals potent blood-brain barrier permeable histone deacetylase inhibitors","volume":"5","author":"Seo","year":"2014","journal-title":"ACS Chem Neurosci"},{"key":"2026100502522911700_noag142-B35","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.1158\/1078-0432.CCR-09-0547","article-title":"JNJ-26481585, a novel second-generation oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity","volume":"15","author":"Arts","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2026100502522911700_noag142-B36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/neuonc\/noaa249","article-title":"Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-na\u00efve diffuse midline glioma models","volume":"23","author":"Vitanza","year":"2021","journal-title":"Neuro Oncol"},{"key":"2026100502522911700_noag142-B37","doi-asserted-by":"publisher","first-page":"113707","DOI":"10.1016\/j.celrep.2024.113707","article-title":"H2A.Z histone variants facilitate HDACi-dependent removal of H3.3K27M mutant protein in pediatric high-grade glioma cells","volume":"43","author":"Leszczynska","year":"2024","journal-title":"Cell Rep"},{"key":"2026100502522911700_noag142-B38","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.3390\/cancers16213565","article-title":"Panobinostat synergizes with chemotherapeutic agents and improves efficacy of standard-of-care chemotherapy combinations in ewing sarcoma cells","volume":"16","author":"Smith","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026100502522911700_noag142-B39","doi-asserted-by":"publisher","first-page":"e167081","DOI":"10.1172\/jci.insight.167081","article-title":"Quisinostat is a brain-penetrant radiosensitizer in glioblastoma","volume":"8","author":"Lo Cascio","year":"2023","journal-title":"JCI Insight"},{"key":"2026100502522911700_noag142-B40","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/nar\/gkx1225","article-title":"Genome-wide dose-dependent inhibition of histone deacetylases studies reveal their roles in enhancer remodeling and suppression of oncogenic super-enhancers","volume":"46","author":"Sanchez","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026100502522911700_noag142-B41","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41588-019-0534-4","article-title":"Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma","volume":"51","author":"Gryder","year":"2019","journal-title":"Nat Genet"},{"key":"2026100502522911700_noag142-B42","doi-asserted-by":"publisher","first-page":"13498","DOI":"10.1021\/ja5060934","article-title":"Strategy for \u201cdetoxification\u201d of a cancer-derived histone mutant based on mapping its interaction with the methyltransferase PRC2","volume":"136","author":"Brown","year":"2014","journal-title":"J Am Chem Soc"},{"key":"2026100502522911700_noag142-B43","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG","volume":"15","author":"Cordero","year":"2017","journal-title":"Mol Cancer Res"},{"key":"2026100502522911700_noag142-B44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat Med"},{"key":"2026100502522911700_noag142-B45","doi-asserted-by":"publisher","first-page":"108994","DOI":"10.1016\/j.celrep.2021.108994","article-title":"Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG","volume":"35","author":"Ehteda","year":"2021","journal-title":"Cell Rep"},{"key":"2026100502522911700_noag142-B46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat Med"},{"key":"2026100502522911700_noag142-B47","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/neuonc\/noaa058","article-title":"Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma","volume":"22","author":"Bailey","year":"2020","journal-title":"Neuro Oncol"},{"key":"2026100502522911700_noag142-B48","doi-asserted-by":"publisher","first-page":"e0169485","DOI":"10.1371\/journal.pone.0169485","article-title":"Pre-clinical study of panobinostat in xenograft and genetically engineered murine diffuse intrinsic pontine glioma models. Castro MG, ed","volume":"12","author":"Hennika","year":"2017","journal-title":"PLoS One"},{"key":"2026100502522911700_noag142-B49","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1093\/neuonc\/noad105","article-title":"PNOC015: Repeated convection-enhanced delivery of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"25","author":"Mueller","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026100502522911700_noag142-B50","doi-asserted-by":"publisher","first-page":"1089898","DOI":"10.3389\/fcell.2022.1089898","article-title":"Epigenetic programming of pediatric high-grade glioma: pushing beyond proof of concept to clinical benefit","volume":"10","author":"Groves","year":"2022","journal-title":"Front Cell Dev Biol"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag142\/68624274\/noag142.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2485\/68624274\/noag142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/10\/2485\/68624274\/noag142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:52:41Z","timestamp":1791183161000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/10\/2485\/8718637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,6,25]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag142","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,6,25]]}}}